Non-Invasive Biomarker to Diagnosis Breast Cancer Metastasis | |
Free Online Advertising Free Internet Web Site Advertising. UK Free Classifieds United Kingdom Free Ads Website. 100% Free Ad Posting. Canada Free Ads Popular Online Classifieds in Canada. No Sign up, No Email Required to Post. According to statistics, 2.3 million women will be diagnosed with breast cancer for the first time in 2020, with one woman diagnosed every fourteen seconds worldwide. It is the most common type of cancer in Singapore, with one in every thirteen women developing it at some point in their lives. Despite the fact that advanced and metastatic breast cancer are thought to be incurable and have a very poor prognosis, early-stage and non-metastatic breast cancer can now be treated. Since early detection of breast cancer metastasis is critical for treatment, a group of researchers has discovered a non-invasive biomarker that may aid in an earlier diagnosis. According to research led by Assistant Professor Minh Le from the Institute for Digital Medicine (WisDM) and Department of Pharmacology at the Yong Loo Lin School of Medicine of the National University of Singapore (NUS Medicine) and Associate Professor Andrew Grimson from the Department of Molecular Biology and Genetics at Cornel University, extracellular vesicles (EVs), which are particles secreted by tumour cells, have a high level of the proteins integrins v and 1. For more details please visit our website - https://www.medhealthreview.com/2025/03/19/non-invasive-biomarker-to-diagnosis-breast-cancer-metastasis/ ![]() | |
Related Link: Click here to visit item owner's website (0 hit) | |
Target State: New York Target City : New York City Last Update : Aug 06, 2025 1:54 AM Number of Views: 22 | Item Owner : medhealthreview Contact Email: Contact Phone: +1 702-213-6364 |
Friendly reminder: Click here to read some tips. |